Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 130, 2024 - Issue 2
109
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Effects of almond consumption on lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

, &
Pages 128-135 | Received 09 Aug 2020, Accepted 24 Sep 2021, Published online: 08 Oct 2021

References

  • Asbaghi, O., et al., 2021. The effect of almond intake on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Food & function, 12 (5), 1882–1896.
  • Barreca, D., et al., 2020. Almonds (Prunus dulcis Mill. DA webb): a source of nutrients and health-promoting compounds. Nutrients, 12 (3), 672.
  • Berryman, C.E., et al., 2011. Effects of almond consumption on the reduction of LDL-cholesterol: a discussion of potential mechanisms and future research directions. Nutrition reviews, 69 (4), 171–185.
  • Blair, M., 2016. Diabetes mellitus review. Urologic nursing, 36 (1), 27.
  • Chen, C.M., et al., 2017. Almonds ameliorate glycemic control in Chinese patients with better controlled type 2 diabetes: a randomized, crossover, controlled feeding trial. Nutrition & metabolism, 14 (1), 1–12.
  • Cohen, A.E. and Johnston, C.S., 2011. Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A(1c) in individuals with well-controlled type 2 diabetes mellitus. Metabolism: clinical and experimental, 60 (9), 1312–1317.
  • Daumerie, C.M., Woollett, L.A., and Dietschy, J.M., 1992. Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proceedings of the national academy of sciences of the United States of America, 89 (22), 10797–10801.
  • Eslampour, E., et al., 2020a. The effect of almond intake on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Complementary therapies in medicine, 50, 102399.
  • Eslampour, E., et al., 2020b. The effect of almond intake on anthropometric indices: a systematic review and meta-analysis. Food & function, 11 (9), 7340–7355.
  • Follmann, D., et al., 1992. Variance imputation for overviews of clinical trials with continuous response. Journal of clinical epidemiology, 45 (7), 769–773.
  • Frank, B., 2010. The role of diet, lifestyle, and genes: globalization of diabetes. Diabetes care, 34, 1249–1257.
  • Franklin, L.M. and Mitchell, A.E., 2019. Review of the sensory and chemical characteristics of almond (Prunus dulcis) flavor. Journal of agricultural and food chemistry, 67 (10), 2743–2753.
  • Găman, M. A., et al., 2020. Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes. Metabolites, 10 (5), 195.
  • Gorji, N., Moeini, R., and Memariani, Z., 2018. Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: a neuropharmacological review of their bioactive constituents. Pharmacological research, 129, 115–127.
  • Higgins, J. P., et al., 2019. Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: John Wiley & Sons.
  • Hill-Briggs, F., et al., 2021. Social determinants of health and diabetes: a scientific review. Diabetes care, 44 (1), 258–279.
  • Hou, Y. Y., et al., 2018. A randomized controlled trial to compare the effect of peanuts and almonds on the cardio-metabolic and inflammatory parameters in patients with type 2 diabetes mellitus. Nutrients, 10 (11), 1565.
  • Jialal, I. and Singh, G., 2019. Management of diabetic dyslipidemia: an update. World journal of diabetes, 10 (5), 280–290.
  • Karimi, Z., et al., 2021. Almond as a nutraceutical and therapeutic agent in Persian medicine and modern phytotherapy: a narrative review. Phytotherapy research, 35 (6), 2997–3012.
  • Kolhar, U. and Priyanka, P., 2017. Study of serum lipid profile in type 2 diabetes mellitus patients and its association with diabetic nephropathy. International journal of advances in medicine, 4 (6), 1513–1516.
  • Lee-Bravatti, M.A., et al., 2019. Almond consumption and risk factors for cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Advances in nutrition, 10 (6), 1076–1088.
  • Li, S. C., et al., 2011. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism: clinical and experimental, 60 (4), 474–479.
  • Liu, J. F., et al., 2013. The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial. European journal of nutrition, 52 (3), 927–935.
  • Liu, Y., et al., 2017. The effects of daily intake timing of almond on the body composition and blood lipid profile of healthy adults. Nutrition research and practice, 11 (6), 479–486.
  • Mihaylova, B., et al., 2012. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet, 380, 581–590.
  • Moher, D., et al., 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine, 6 (7), e1000097.
  • Musa-Veloso, K., et al., 2016. The effects of almond consumption on fasting blood lipid levels: a systematic review and meta-analysis of randomised controlled trials. Journal of nutritional science, 5, e34.
  • Poznyak, A., et al., 2020. The diabetes mellitus–atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. International journal of molecular sciences, 21 (5), 1835.
  • Richmond, K., et al., 2013. Markers of cardiovascular risk in postmenopausal women with type 2 diabetes are improved by the daily consumption of almonds or sunflower kernels: a feeding study. ISRN nutrition, 2013, 626414.
  • Roncero, J.M., et al., 2020. Review about non-lipid components and minor fat-soluble bioactive compounds of almond kernel. Foods, 9 (11), 1646.
  • Sowers, J.R. and Lester, M.A., 1999. Diabetes and cardiovascular disease. Diabetes care, 22, C14.
  • Sweazea, K.L., et al., 2014. Almond supplementation in the absence of dietary advice significantly reduces C-reactive protein in subjects with type 2 diabetes. Journal of functional foods, 10, 252–259.
  • Tahir, F.N., et al., 2018. Effect of almond consumption on serum lipid profile in dyslipidemic adults. Pakistan journal of medical & health sciences, 12, 573–575.
  • Takeuchi, H., et al., 2001. Comparative effects of dietary fat types on hepatic enzyme activities related to the synthesis and oxidation of fatty acid and to lipogenesis in rats. Bioscience, biotechnology, and biochemistry, 65 (8), 1748–1754.
  • Wang, C., et al., 2020. Effects of probiotic supplementation on dyslipidemia in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Foods, 9 (11), 1540.
  • Williams, R., et al., 2020. Global and regional estimates and projections of diabetes-related health expenditure: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes research and clinical practice, 162, 108072.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.